Timothy P Sullivan

Director Timothy Sullivan buys ~24K shares at depressed valuations amid broader insider buying cluster.

Timothy P Sullivan, a director at Option Care Health, purchased a substantial stake representing nearly half his existing holdings at a time when the stock trades well below its recent highs, suggesting he sees value in the pullback. The company itself remains fundamentally sound — profitable with growing revenue — making this not a rescue bid for a struggling business but rather a conviction buy during a price dislocation. Sullivan's own track record on this stock shows he has timed prior purchases well, with shares rising after his last buy, lending credibility to his current judgment. The purchase also occurs within a window where two other insiders bought as well, indicating that this isn't an isolated director's gamble but part of a coordinated pattern of insider confidence in the stock's trajectory.

Director Timothy Sullivan buys 20,000 OPCH shares at $27.51; holdings increase 68.4% amid 3-stock insider cluster buy within 14 days.

Director Timothy Sullivan purchased 20,000 shares ($550,200.00 total value) on 2025-08-21 at $27.51, raising his stake from 29,229 to 49,229 shares—a 68.4% increase in his holdings. This buy occurred as part of a cluster pattern: 3 other insiders also purchased within the past 14 days, suggesting coordinated director-level accumulation activity. The stock is currently trading at $27.84, down 20.9% from its 52-week high and off 6.5% over the past 30 days, providing context for the timing of this purchase. Notably, Sullivan's prior trade at OPCH (a sell on 2024-08-22) was well-timed at the 90-day mark, indicating a track record of disciplined transaction execution at this ticker, though the current buy's forward-looking merit remains to be established.

Director Timothy P Sullivan sells 47,249 shares of OPCH at $30.91, reducing stake by 69.4% to 20,814 shares

Director Timothy P Sullivan executed a substantial sale of 47,249 shares at $30.91 on 2024-08-22, totaling $1,460,589.44 and reducing his holdings from 68,063 shares to 20,814 shares—a 69.4% reduction in his position. The transaction occurred at a price $0.17 below the current market price of $31.08 and near the midpoint of the 52-week range ($26.63–$35.45). While Option Care Health's fundamentals remain solid with $1.2B in quarterly revenue, +9.1% annual growth, and a $53.0M net income, the magnitude of the stake reduction—eliminating nearly two-thirds of his holdings—represents a material change in insider ownership and warrants closer scrutiny of his remaining 20,814 shares for any pattern or disclosed rationale in the filing.